Related references
Note: Only part of the references are listed.Estrogen Mediation of Breast Tumor Formation Involves Estrogen Receptor-Dependent, as Well as Independent, Genotoxic Effects
Richard Santen et al.
STEROID ENZYMES AND CANCER (2009)
Dihydroartemisinin inhibits growth of pancreatic cancer cells in vitro and in vivo
Hua Chen et al.
ANTI-CANCER DRUGS (2009)
Artemisinin induces doxorubicin resistance in human colon cancer cells via calcium-dependent activation of HIF-1α and P-glycoprotein overexpression
C. Riganti et al.
BRITISH JOURNAL OF PHARMACOLOGY (2009)
Transferrin receptor-dependent cytotoxicity of artemisinin-transferrin conjugates on prostate cancer cells and induction of apoptosis
Ikuhiko Nakase et al.
CANCER LETTERS (2009)
Pharmacokinetics and Pharmacodynamics of Endoperoxide Antimalarials
Anirudh Gautam et al.
CURRENT DRUG METABOLISM (2009)
Stress-Activated MAP Kinase Cascades in Cellular Senescence
Junichi Maruyama et al.
CURRENT MEDICINAL CHEMISTRY (2009)
Chemokine Receptors as Targets for Cancer Therapy
Xuesong Wu et al.
CURRENT PHARMACEUTICAL DESIGN (2009)
Endocrine therapy for the treatment of postmenopausal women with breast cancer
Seema Harichand-Herdt et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2009)
Master regulation of bile acid and xenobiotic metabolism via the FXR, PXR and CAR trio
Salvatore Modica et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2009)
Artemisinin reduces human melanoma cell migration by down-regulating αVβ3 integrin and reducing metalloproteinase 2 production
Elisabetta Buommino et al.
INVESTIGATIONAL NEW DRUGS (2009)
Indole-3-carbinol Inhibits Sp1-Induced Matrix Metalloproteinase-2 Expression To Attenuate Migration and Invasion of Breast Cancer Cells
Wen-Chun Hung et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2009)
Artemisinin Blocks Prostate Cancer Growth and Cell Cycle Progression by Disrupting Sp1 Interactions with the Cyclin-dependent Kinase-4 (CDK4) Promoter and Inhibiting CDK4 Gene Expression
Jamin A. Willoughby et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Androgen receptor knockout and knock-in mouse models
S. Kerkhofs et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2009)
Understanding the Epidemiology, Natural History, and Key Pathways Involved in Prostate Cancer
E. David Crawford
UROLOGY (2009)
Dihydroartemisinin (DHA) induces caspase-3-dependent apoptosis in human lung adenocarcinoma ASTC-a-1 cells
Ying-Ying Lu et al.
JOURNAL OF BIOMEDICAL SCIENCE (2009)
Induction of P-glycoprotein expression and function in human intestinal epithelial cells (T84)
I. S. Haslam et al.
BIOCHEMICAL PHARMACOLOGY (2008)
Artesunate derived from traditional Chinese medicine induces DNA damage and repair
Paul C. H. Li et al.
CANCER RESEARCH (2008)
Artemisinin selectively decreases functional levels of estrogen receptor-alpha and ablates estrogen-induced proliferation in human breast cancer cells
Shyam N. Sundar et al.
CARCINOGENESIS (2008)
Experimental therapy of hepatoma with artemisinin and its derivatives:: In vitro and in vivo activity, chemosensitization, and mechanisms of action
Junmei Hou et al.
CLINICAL CANCER RESEARCH (2008)
Survivin: Key regulator of mitosis and apoptosis and novel target for cancer therapeutics
Alain C. Mita et al.
CLINICAL CANCER RESEARCH (2008)
Apoptotic Signaling Pathways as a Target for the Treatment of Liver Diseases
J. L. Mauriz et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2008)
New insights into the classical and non-classical actions of estrogen: Evidence from estrogen receptor knock-out and knock-in mice
Melissa A. McDevitta et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2008)
Dihydroartemisinin potentiates the cytotoxic effect of temozolomide in rat C6 glioma cells
Xiao-Jia Huang et al.
PHARMACOLOGY (2008)
ER beta in breast cancer - Onlooker, passive player, or active protector?
Emily M. Fox et al.
STEROIDS (2008)
Understanding artemisinin-induced brainstem neurotoxicity
Raymond F. Genovese et al.
ARCHIVES OF TOXICOLOGY (2008)
The role of calcium, P38 MAPK in dihydroartemisinin-induced apoptosis of lung cancer PC-14 cells
Deguang Mu et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2008)
Investigation of the immunosuppressive activity of artemether on T-cell activation and proliferation
J-X Wang et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
Anti-inflammatory properties and regulatory mechanism of a novel derivative of artemisinin in experimental autoimmune encephalomyelitis
Zhaojun Wang et al.
JOURNAL OF IMMUNOLOGY (2007)
Tamoxifen induction of CCAAT enhancer-binding protein α is required for tamoxifen-induced apoptosis
Jingwei Cheng et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Role of Transferrin Receptor and the ABC Transporters ABCB6 and ABCB7 for Resistance and Differentiation of Tumor Cells towards Artesunate
Gerhard Kelter et al.
PLOS ONE (2007)
Artesunate inhibits angiogenesis and downregulates vascular endothelial growth factor expression in chronic myeloid leukemia K562 cells
Hui-Jun Zhou et al.
VASCULAR PHARMACOLOGY (2007)
Dihydroartemisinin is an inhibitor of ovarian cancer cell growth
Yang Jiao et al.
ACTA PHARMACOLOGICA SINICA (2007)
Positive cross-regulatory loop ties GATA-3 to estrogen receptor α expression in breast cancer
Jerome Eeckhoute et al.
CANCER RESEARCH (2007)
Effects of artemisinin and its derivatives on growth inhibition and apoptosis of oral cancer cells
Woong Nam et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2007)
Calcium and survivin are involved in the induction of apoptosis by dihydroartemisinin in human lung cancer SPC-A-1 cells
D. Mu et al.
METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY (2007)
Indole-3-carbinol selectively uncouples expression and activity of estrogen receptor subtypes in human breast cancer cells
Shyam N. Sundar et al.
MOLECULAR ENDOCRINOLOGY (2006)
p38 and ERK MAP kinase mediates iron chelator-induced apoptosis and -suppressed differentiation of immortalized and malignant human oral keratinocytes
Sun-Kyung Lee et al.
LIFE SCIENCES (2006)
Second generation, orally active, antimalarial, artemisinin-derived trioxane dimers with high stability, efficacy, and anticancer activity
IH Paik et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Oral artemisinin prevents and delays the development of 7,12-dimethylbenz[a]anthracene (DMBA)-induced breast cancer in the rat
H Lai et al.
CANCER LETTERS (2006)
Effects of the antimalarial drug dihydroartemisinin (DHA) on rat embryos in vitro
M Longo et al.
REPRODUCTIVE TOXICOLOGY (2006)
The p38 MAPK pathway mediates interleukin-1-induced Sertoli cell proliferation
C Petersen et al.
CYTOKINE (2005)
Acquired resistance to oestrogen deprivation: role for growth factor signalling kinases/oestrogen receptor cross-talk revealed in new MCF-7X model
CM Staka et al.
ENDOCRINE-RELATED CANCER (2005)
Antimalarial artemisinin drugs induce cytochrome p450 and MDR1 expression by activation of xenosensors pregnane X receptor and constitutive androstane receptor
O Burk et al.
MOLECULAR PHARMACOLOGY (2005)
Signal transduction pathways in androgen-dependent and -independent prostate cancer cell proliferation
PM Ghosh et al.
ENDOCRINE-RELATED CANCER (2005)
The mechanisms and managements of hormone-therapy resistance in breast and prostate cancers
KM Rau et al.
ENDOCRINE-RELATED CANCER (2005)
Combination-treatment of glioblastoma multiforme cell lines with the anti-malarial artesunate and the epidermal growth factor receptor tyrosine kinase inhibitor OSI-774
T Efferth et al.
BIOCHEMICAL PHARMACOLOGY (2004)
Androgen receptor in prostate cancer
CA Heinlein et al.
ENDOCRINE REVIEWS (2004)
Estrogen receptor β inhibits 17β-estradiol-stimulated proliferation of the breast cancer cell line T47D
A Ström et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Inhibition of estrogen receptor alpha expression and function in MCF-7 cells by kaempferol
H Hung
JOURNAL OF CELLULAR PHYSIOLOGY (2004)
Enhancement of cytotoxicity of artemisinins toward cancer cells by ferrous iron
T Efferth et al.
FREE RADICAL BIOLOGY AND MEDICINE (2004)
Estrogen receptor beta inhibits human breast cancer cell proliferation and tumor formation by causing a G(2) cell cycle arrest
S Paruthiyil et al.
CANCER RESEARCH (2004)
Molecular modes of action of artesunate in tumor cell lines
T Efferth et al.
MOLECULAR PHARMACOLOGY (2003)
Risk for subsequent development of breast cancer - Authors' reply
A Shaaban et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2003)
The antimalaria agent artemisinin exerts antiangiogenic effects in mouse embryonic stem cell-derived embryoid bodies
M Wartenberg et al.
LABORATORY INVESTIGATION (2003)
Costunolide, a sesquiterpene lactone from Saussurea lappa, inhibits the VEGFR KDR/Flk-1 signaling pathway
SJ Jeong et al.
CANCER LETTERS (2002)
Artemisinin: mechanisms of action, resistance and toxicity
SR Meshnick
INTERNATIONAL JOURNAL FOR PARASITOLOGY (2002)
mRNA expression profiles for the response of human tumor cell lines to the antimalarial drugs artesunate, arteether, and artemether
T Efferth et al.
BIOCHEMICAL PHARMACOLOGY (2002)
The influence of the route of administration of 17β-estradiol, intravenous (pulsed) versus oral, upon DMBA-Induced mammary tumour development in ovariectomised rats
B Kerdelhué et al.
BREAST CANCER RESEARCH AND TREATMENT (2002)
Inhibition of glutathione S-transferases by antimalarial drugs possible implications for circumventing anticancer drug resistance
S Mukanganyama et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
Share Paper
